These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 34494884

  • 1. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection In Vivo.
    Cartwright HN, Barbeau DJ, McElroy AK.
    mSphere; 2021 Oct 27; 6(5):e0055621. PubMed ID: 34494884
    [Abstract] [Full Text] [Related]

  • 2. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.
    PLoS Negl Trop Dis; 2013 Oct 27; 7(7):e2309. PubMed ID: 23875044
    [Abstract] [Full Text] [Related]

  • 3. Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
    Gutjahr B, Keller M, Rissmann M, von Arnim F, Jäckel S, Reiche S, Ulrich R, Groschup MH, Eiden M.
    PLoS Negl Trop Dis; 2020 Mar 27; 14(3):e0008143. PubMed ID: 32160203
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis.
    Connors KA, Chapman NS, McMillen CM, Hoehl RM, McGaughey JJ, Frey ZD, Midgett M, Williams C, Reed DS, Crowe JE, Hartman AL.
    JCI Insight; 2024 Aug 01; 9(18):. PubMed ID: 39088277
    [Abstract] [Full Text] [Related]

  • 7. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH, Wang XJ, Hu S, Ge JY, Bu ZG.
    Wei Sheng Wu Xue Bao; 2007 Aug 01; 47(4):677-81. PubMed ID: 17944371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B, Wilson WC, Gaudreault NN, Davis AS, Shivanna V, Bawa B, Sunwoo SY, Ma W, Drolet BS, Morozov I, McVey DS, Richt JA.
    Sci Rep; 2016 Jun 14; 6():27719. PubMed ID: 27296136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K, Tercero BR, Makino S.
    Virus Res; 2016 May 02; 216():55-65. PubMed ID: 26022573
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus.
    Ma J, Chen R, Huang W, Nie J, Liu Q, Wang Y, Yang X.
    Hum Vaccin Immunother; 2019 May 02; 15(10):2286-2294. PubMed ID: 31170027
    [Abstract] [Full Text] [Related]

  • 16. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
    Chapman NS, Zhao H, Kose N, Westover JB, Kalveram B, Bombardi R, Rodriguez J, Sutton R, Genualdi J, LaBeaud AD, Mutuku FM, Pittman PR, Freiberg AN, Gowen BB, Fremont DH, Crowe JE.
    Proc Natl Acad Sci U S A; 2021 Apr 06; 118(14):. PubMed ID: 33782133
    [Abstract] [Full Text] [Related]

  • 17. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
    Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albariño CG.
    J Virol; 2012 Apr 06; 86(8):4204-12. PubMed ID: 22345465
    [Abstract] [Full Text] [Related]

  • 18. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK, Rurangirwa FR, McGuire TC, Rwambo PM, DeMartini JC, Crawford TB.
    Clin Vaccine Immunol; 2010 Dec 06; 17(12):1842-9. PubMed ID: 20876822
    [Abstract] [Full Text] [Related]

  • 19. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
    Hao M, Zhang G, Zhang S, Chen Z, Chi X, Dong Y, Fan P, Liu Y, Chen Y, Song X, Liu S, Yu C, Li J, Xia X.
    Viruses; 2020 Feb 27; 12(3):. PubMed ID: 32120864
    [Abstract] [Full Text] [Related]

  • 20. Equine immunoglobulin F(ab')2 fragments protect mice from Rift Valley fever virus infection.
    Zhao Y, Zheng X, He S, Li Y, Wang W, Gai W, Wong G, Wang H, Yan F, Xue F, Feng N, Wang T, Gao Y, Yang S, Qiu X, Xia X.
    Int Immunopharmacol; 2018 Nov 27; 64():217-222. PubMed ID: 30199846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.